Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Biomolecules and Biomedicine is Scopus-indexed (Q1, CiteScore 4.7), WoS SCIE, DOAJ. Published by Association of Basic Medical Sciences of FBIH.
Checked against the index lists dated .
ISSN 2831-0896Verify ISSN ↗2831-090XVerify ISSN ↗
Publisher: Association of Basic Medical Sciences of FBIH
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Medicine (all) | 105 / 669 | 84th | Q1 |
| Biochemistry, Genetics and Molecular Biology (all) | 83 / 223 | 63rd | Q2 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2023–present, best quartile Q1, CiteScore 4.7.
Biomolecules and Biomedicine is Q1 in Medicine (all) (rank 105 of 669) and Q2 in Biochemistry, Genetics and Molecular Biology (all) (rank 83 of 223), by CiteScore 2025.
Biomolecules and Biomedicine is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 4.7, which places it in quartile Q1 at the 84th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.848, quartile Q2, with an H-index of 50.
Biomolecules and Biomedicine is published by Association of Basic Medical Sciences of FBIH. Its print ISSN is 2831-0896 and its online ISSN is 2831-090X.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal, listed in DOAJ.
Biomolecules and Biomedicine has an h-index of 37 and a 2-year mean of 3.01 citations per paper (OpenAlex). Its Scopus CiteScore is 4.7, quartile Q1. On 2-year citations it ranks #88 of 646 Scopus journals in Medicine (all).
Biomolecules and Biomedicine published 214 papers in 2025; its busiest recent year was 2024 with 235. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 100 research articles (2026), authors are most often from China (27.3%), Türkiye (20%) and Serbia (6.1%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 3 retracted papers are recorded (2.7 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.